The BioPharma Shares Rising On Omicron Hopes And Fears

Room For New Options In Vaccines And Antibodies

Adagio Therapeutics and Gritstone bio are two companies who could add to the armamentarium against Omicron.

London Waterloo train station
Waterloo station, London, UK: confirmed cases of the new variant have led the government to reimpose mandatory mask wearing on public transport. • Source: Alamy

Concerns about the danger posed by the Omicron SARS-CoV2 variant have gripped the world in the last week, even while public health scientists and biopharma researchers race to establish if, as feared, it proves to be more transmissible than previous variants and potentially evade existing vaccines.

But just as at the outset of the pandemic in early 2020, a handful of biopharma companies who might have...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip